Bahian, Emelia S.

HRN: 22-23-85  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/22/2022
12/28/2022
IV INFUSION TO RUN FOR 6 HOURS
1.5 G
Q6H
Community Acquired Pneumonia- High Risk
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: